Cargando…

Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders

Detalles Bibliográficos
Autores principales:	Ries, Markus, Lutz, Thomas, Lampert, Anette, Mountford, William, Mechler, Konstantin, Hoffmann, Georg F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715114/ https://www.ncbi.nlm.nih.gov/pubmed/27484192 http://dx.doi.org/10.1186/2194-7791-2-S1-A1

Ejemplares similares

Pressure for drug development in lysosomal storage disorders – a quantitative analysis thirty years beyond the US orphan drug act
por: Mechler, Konstantin, et al.
Publicado: (2015)

Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act
por: Lutz, Thomas, et al.
Publicado: (2016)

FDA orphan drug designations for lysosomal storage disorders – a cross-sectional analysis
por: Garbade, Sven F., et al.
Publicado: (2020)

Disease awareness or subtle product placement? Orphan diseases featured in the television series “House, M.D.” - a cross-sectional analysis
por: Mechler, Konstantin, et al.
Publicado: (2020)

Thirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional Analysis
por: Döring, Jan Henje, et al.
Publicado: (2016)

The earth's open wounds: abandoned and orphaned mines.
por: Fields, Scott
Publicado: (2003)

Mechanism of coordinated access to orphan drugs
por: DeRidder, R, et al.
Publicado: (2012)

Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
por: Hollak, Carla EM, et al.
Publicado: (2011)

What Is the Purpose of the Orphan Drug Act?
por: Herder, Matthew
Publicado: (2017)

Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019)

Orf – an orphan disease?
por: Meier, Rahel, et al.
Publicado: (2015)

Leveraging existing opportunities for improved Orphan Drug approval in the EU
por: Edfjäll, Catarina
Publicado: (2012)

Child work and labour among orphaned and abandoned children in five low and middle income countries
por: Whetten, Rachel, et al.
Publicado: (2011)

Meiosis Research in Orphan and Non-orphan Tropical Crops
por: Bolaños-Villegas, Pablo, et al.
Publicado: (2019)

The impact of the rare disease and Orphan Drug Act in Taiwan
por: Hsiang, Ning-Chun, et al.
Publicado: (2021)

Orphan receptors.
Publicado: (1993)

The Orphans’ Home
Publicado: (1867)

Market access of orphan drugs and the role of multi-criteria decision making
por: Simoens, Steven
Publicado: (2012)

Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union
por: Żelewski, Paweł, et al.
Publicado: (2022)

Correlates of Poor Health among Orphans and Abandoned Children in Less Wealthy Countries: The Importance of Caregiver Health
por: Thielman, Nathan, et al.
Publicado: (2012)

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
por: Eichler, Hans-Georg, et al.
Publicado: (2023)

EHMTI-0248. Evaluation of headache prevalence and characteristics in orphans aged 12-17
por: Senturk, A Ates, et al.
Publicado: (2014)

10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Publicado: (2020)

Orphan Crops Browser: a bridge between model and orphan crops
por: Kamei, Claire Lessa Alvim, et al.
Publicado: (2016)

Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act
por: Chambers, James D., et al.
Publicado: (2023)

Orphan drug development in alpha-1 antitypsin deficiency
por: Trudzinski, Franziska C., et al.
Publicado: (2022)

A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the forty years of the Orphan Drug Act
por: Fermaglich, Lewis J., et al.
Publicado: (2023)

Profiling the orphan enzymes
por: Sorokina, Maria, et al.
Publicado: (2014)

The mysterious orphans of Mycoplasmataceae
por: Tatarinova, Tatiana V., et al.
Publicado: (2016)

The Orphan Working School
por: Frankau, F. J.
Publicado: (1918)

The Orphan Working School
Publicado: (1892)

Pensions: Widows and Orphans
Publicado: (1909)

Orphan Peripheral Neuropathies
por: Finsterer, Josef, et al.
Publicado: (2021)

The State’s Duty to the Orphan
por: Spratling, Edgar J.
Publicado: (1902)

What can we learn about joint degeneration from rare and orphan diseases?
por: Gallagher, JA
Publicado: (2015)

Estimating the clinical cost of drug development for orphan versus non-orphan drugs
por: Jayasundara, Kavisha, et al.
Publicado: (2019)

Anxiety, Depression, Stress, and Decision-Making Among Orphans and Non-Orphans in Pakistan
por: Shafiq, Farah, et al.
Publicado: (2020)

The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America
por: Arnold, Renée J.G., et al.
Publicado: (2015)

Investigating the landscape of US orphan product approvals
por: Miller, Kathleen L., et al.
Publicado: (2018)

Elucidation of primary metabolic pathways in Aspergillus species: Orphaned research in characterizing orphan genes
por: Andersen, Mikael Rørdam
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9ot5cjk7a655nqeq9n32qal0kh